Advances in the Experimental Models of HIV-Associated Neurological Disorders

Purpose of Review Involvement of the central nervous system (CNS) in HIV-1 infection is commonly associated with neurological disorders and cognitive impairment, commonly referred to as HIV-associated neurocognitive disorders (HAND). Severe and progressive neurocognitive impairment is rarely observed in the post-cART era; however, asymptomatic and mild neurocognitive disorders still exist, despite viral suppression. Additionally, comorbid conditions can also contribute to the pathogenesis of HAND. Recent Findings In this review, we summarize the characterization of HAND, factors contributing, and the functional impairments in both preclinical and clinical models. Specifically, we also discuss recent advances in the animal models of HAND and in in vitro cultures and the potential role of drugs of abuse in this model system of HAND. Potential peripheral biomarkers associated with HAND are also discussed. Summary Overall, this review identifies some of the recent advances in the field of HAND in cell culture studies, animal models, clinical findings, and the limitations of each model system, which can play a key role in developing novel therapeutics in the field.

Automated summary

This review summarizes the characteristics of HIV-associated neurocognitive disorders (HAND), factors contributing to HAND, and functional impairments in preclinical and clinical models. Recent advances in animal models of HAND, in vitro cultures, and the potential role of drugs of abuse in HAND are also discussed. Potential peripheral biomarkers associated with HAND are highlighted as well.